[1]
Balding SD,Prost C,Diaz LA,Bernard P,Bedane C,Aberdam D,Giudice GJ, Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. The Journal of investigative dermatology. 1996 Jan
[PubMed PMID: 8592065]
[2]
Domloge-Hultsch N,Gammon WR,Briggaman RA,Gil SG,Carter WG,Yancey KB, Epiligrin, the major human keratinocyte integrin ligand, is a target in both an acquired autoimmune and an inherited subepidermal blistering skin disease. The Journal of clinical investigation. 1992 Oct
[PubMed PMID: 1401088]
[3]
Tyagi S,Bhol K,Natarajan K,Livir-Rallatos C,Foster CS,Ahmed AR, Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization. Proceedings of the National Academy of Sciences of the United States of America. 1996 Dec 10
[PubMed PMID: 8962120]
[4]
Bernard P,Vaillant L,Labeille B,Bedane C,Arbeille B,Denoeux JP,Lorette G,Bonnetblanc JM,Prost C, Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group. Archives of dermatology. 1995 Jan
[PubMed PMID: 7826096]
[5]
Zillikens D,Wever S,Roth A,Weidenthaler-Barth B,Hashimoto T,Br�cker EB, Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Archives of dermatology. 1995 Aug
[PubMed PMID: 7669112]
[6]
Laskaris G,Sklavounou A,Stratigos J, Bullous pemphigoid, cicatricial pemphigoid, and pemphigus vulgaris. A comparative clinical survey of 278 cases. Oral surgery, oral medicine, and oral pathology. 1982 Dec
[PubMed PMID: 6760033]
Level 2 (mid-level) evidence
[7]
Hong GH,Khan IR,Shifera AS,Okeagu C,Thorne JE, Incidence and Clinical Characteristics of Ocular Involvement in Mucous Membrane Pemphigoid. Ocular immunology and inflammation. 2018 Apr 19
[PubMed PMID: 29672212]
[8]
Chan LS,Wang T,Wang XS,Hammerberg C,Cooper KD, High frequency of HLA-DQB1*0301 allele in patients with pure ocular cicatricial pemphigoid. Dermatology (Basel, Switzerland). 1994
[PubMed PMID: 8049575]
[9]
Lee JB,Liu Y,Hashimoto T, Cicatricial pemphigoid sera specifically react with the most C-terminal portion of BP180. Journal of dermatological science. 2003 Jun
[PubMed PMID: 12788530]
[10]
B�dane C,McMillan JR,Balding SD,Bernard P,Prost C,Bonnetblanc JM,Diaz LA,Eady RA,Giudice GJ, Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida. The Journal of investigative dermatology. 1997 Jun
[PubMed PMID: 9182819]
[12]
Bhol KC,Dans MJ,Simmons RK,Foster CS,Giancotti FG,Ahmed AR, The autoantibodies to alpha 6 beta 4 integrin of patients affected by ocular cicatricial pemphigoid recognize predominantly epitopes within the large cytoplasmic domain of human beta 4. Journal of immunology (Baltimore, Md. : 1950). 2000 Sep 1
[PubMed PMID: 10946315]
[13]
Li X,Qian H,Sogame R,Hirako Y,Tsuruta D,Ishii N,Koga H,Tsuchisaka A,Jin Z,Tsubota K,Fukumoto A,Sotozono C,Kinoshita S,Hashimoto T, Integrin ?4 is a major target antigen in pure ocular mucous membrane pemphigoid. European journal of dermatology : EJD. 2016 Jun 1
[PubMed PMID: 27193492]
Level 2 (mid-level) evidence
[15]
Gallagher G,Shklar G, Oral involvement in mucous membrane pemphigoid. Clinics in dermatology. 1987 Jan-Mar
[PubMed PMID: 3552187]
[17]
Hanson RD,Olsen KD,Rogers RS 3rd, Upper aerodigestive tract manifestations of cicatricial pemphigoid. The Annals of otology, rhinology, and laryngology. 1988 Sep-Oct
[PubMed PMID: 3052224]
[18]
Lazor JB,Varvares MA,Montgomery WW,Goodman ML,Mackool BT, Management of airway obstruction in cicatricial pemphigoid. The Laryngoscope. 1996 Aug
[PubMed PMID: 8699892]
[19]
Hardy KM,Perry HO,Pingree GC,Kirby TJ Jr, Benign mucous membrane pemphigoid. Archives of dermatology. 1971 Nov
[PubMed PMID: 5120174]
[20]
Lever WF, Pemphigus and pemphigoid. A review of the advances made since 1964. Journal of the American Academy of Dermatology. 1979 Jul
[PubMed PMID: 387823]
Level 3 (low-level) evidence
[21]
Bean SF,Waisman M,Michel B,Thomas CI,Knox JM,Levine M, Cicatricial pemphigoid. Immunofluorescent studies. Archives of dermatology. 1972 Aug
[PubMed PMID: 4558699]
[22]
Leonard JN,Wright P,Williams DM,Gilkes JJ,Haffenden GP,McMinn RM,Fry L, The relationship between linear IgA disease and benign mucous membrane pemphigoid. The British journal of dermatology. 1984 Mar
[PubMed PMID: 6365149]
[23]
Shimanovich I,Nitz JM,Zillikens D, Multiple and repeated sampling increases the sensitivity of direct immunofluorescence testing for the diagnosis of mucous membrane pemphigoid. Journal of the American Academy of Dermatology. 2017 Oct
[PubMed PMID: 28676329]
[24]
Yasukochi A,Teye K,Ishii N,Hashimoto T, Clinical and Immunological Studies of 332 Japanese Patients Tentatively Diagnosed as Anti-BP180-type Mucous Membrane Pemphigoid: A Novel BP180 C-terminal Domain Enzyme-linked Immunosorbent Assay. Acta dermato-venereologica. 2016 Aug 23
[PubMed PMID: 26984589]
[25]
Sezin T,Egozi E,Hillou W,Avitan-Hersh E,Bergman R, Anti-laminin-332 mucous membrane pemphigoid developing after a diphtheria tetanus vaccination. JAMA dermatology. 2013 Jul
[PubMed PMID: 23700098]
[26]
Knudson RM,Kalaaji AN,Bruce AJ, The management of mucous membrane pemphigoid and pemphigus. Dermatologic therapy. 2010 May-Jun
[PubMed PMID: 20597945]
[27]
Aufdemorte TB,De Villez RL,Parel SM, Modified topical steroid therapy for the treatment of oral mucous membrane pemphigoid. Oral surgery, oral medicine, and oral pathology. 1985 Mar
[PubMed PMID: 3885134]
[28]
Assmann T,Becker J,Ruzicka T,Megahed M, Topical tacrolimus for oral cicatricial pemphigoid. Clinical and experimental dermatology. 2004 Nov
[PubMed PMID: 15550151]
[29]
Rogers RS 3rd,Seehafer JR,Perry HO, Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone. Journal of the American Academy of Dermatology. 1982 Feb
[PubMed PMID: 7037880]
[30]
Megahed M,Schmiedeberg S,Becker J,Ruzicka T, Treatment of cicatricial pemphigoid with mycophenolate mofetil as a steroid-sparing agent. Journal of the American Academy of Dermatology. 2001 Aug
[PubMed PMID: 11464188]
[31]
Nottage JM,Hammersmith KM,Murchison AP,Felipe AF,Penne R,Raber I, Treatment of mucous membrane pemphigoid with mycophenolate mofetil. Cornea. 2013 Jun
[PubMed PMID: 23132447]
[32]
Pasadhika S,Kempen JH,Newcomb CW,Liesegang TL,Pujari SS,Rosenbaum JT,Thorne JE,Foster CS,Jabs DA,Levy-Clarke GA,Nussenblatt RB,Suhler EB, Azathioprine for ocular inflammatory diseases. American journal of ophthalmology. 2009 Oct
[PubMed PMID: 19570522]
[33]
Pujari SS,Kempen JH,Newcomb CW,Gangaputra S,Daniel E,Suhler EB,Thorne JE,Jabs DA,Levy-Clarke GA,Nussenblatt RB,Rosenbaum JT,Foster CS, Cyclophosphamide for ocular inflammatory diseases. Ophthalmology. 2010 Feb
[PubMed PMID: 19969366]
[34]
Letko E,Miserocchi E,Daoud YJ,Christen W,Foster CS,Ahmed AR, A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies. Clinical immunology (Orlando, Fla.). 2004 Jun
[PubMed PMID: 15183151]
Level 2 (mid-level) evidence
[35]
Ma L,You C,Hernandez M,Maleki A,Lasave A,Schmidt A,Stephenson A,Zhao T,Anesi S,Foster CS, Management of Ocular Cicatricial Pemphigoid with Intravenous Immunoglobulin Monotherapy. Ocular immunology and inflammation. 2018 Mar 8
[PubMed PMID: 29517945]
[36]
Sacher C,Rubbert A,K�nig C,Scharffetter-Kochanek K,Krieg T,Hunzelmann N, Treatment of recalcitrant cicatricial pemphigoid with the tumor necrosis factor alpha antagonist etanercept. Journal of the American Academy of Dermatology. 2002 Jan
[PubMed PMID: 11756956]
[37]
Prey S,Robert PY,Drouet M,Sparsa A,Roux C,Bonnetblanc JM,B�dane C, Treatment of ocular cicatricial pemphigoid with the tumour necrosis factor alpha antagonist etanercept. Acta dermato-venereologica. 2007
[PubMed PMID: 17225020]
[38]
Maley A,Warren M,Haberman I,Swerlick R,Kharod-Dholakia B,Feldman R, Rituximab combined with conventional therapy versus conventional therapy alone for the treatment of mucous membrane pemphigoid (MMP). Journal of the American Academy of Dermatology. 2016 May
[PubMed PMID: 26936298]
[39]
Shetty S,Ahmed AR, Critical analysis of the use of rituximab in mucous membrane pemphigoid: a review of the literature. Journal of the American Academy of Dermatology. 2013 Mar
[PubMed PMID: 23200198]
[40]
Roenigk HH Jr,Ryan JG,Bergfeld WF, Epidermolysis bullosa acquisita. Report of three cases and review of all published cases. Archives of dermatology. 1971 Jan
[PubMed PMID: 4321800]
Level 3 (low-level) evidence
[41]
Joseph TI,Sathyan P,Goma Kumar KU, Linear IgA dermatosis adult variant with oral manifestation: A rare case report. Journal of oral and maxillofacial pathology : JOMFP. 2015 Jan-Apr
[PubMed PMID: 26097313]
Level 3 (low-level) evidence
[42]
Ramos-Castell�n C,Ortiz-Nieva G,Fres�n F,Villalvazo L,Garfias Y,Navas A,Jim�nez-Mart�nez MC, Ocular involvement and blindness secondary to linear IgA dermatosis. Journal of ophthalmology. 2010
[PubMed PMID: 21234343]
[43]
Fiore PM,Jacobs IH,Goldberg DB, Drug-induced pemphigoid. A spectrum of diseases. Archives of ophthalmology (Chicago, Ill. : 1960). 1987 Dec
[PubMed PMID: 3318771]